Naga Chalasani MD

PubMed

• 3 citations
  Natural history and development of a novel composite endpoint in patients with alcohol-associated hepatitis: Data from a prospective multicenter study.
  Srinivasan Dasarathy, Wanzhu Tu, Nicole Welch, Samer Gawrieh, Yunpeng Yu
  Hepatology. 2026-06-01
• 1 citations
  Physical exercise improves neurocognition in patients with metabolic dysfunction-associated steatotic liver disease.
  Berenice Monserrat Román-Calleja, Astrid Ruiz-Margain, Andres Duarte-Rojo, Fernando Flores-Silva, Carlos Fernando Martinez-Cabrera
  Liver Transplantation. 2026-06-01
• 2 citations
  Biological Age, PNPLA3, and Risk of Metabolic Dysfunction-associated Steatotic Liver Disease.
  Samer Gawrieh, Jie Yao, Xiuqing Guo, Anna Mae Diehl, Jerome I Rotter
  Clinical Gastroenterology and Hepatology. 2026-04-01

Journal Articles

• In a Pilot Study, Reduced Fatty Acid Desaturase 1 Function Was Associated with Nonalcoholic Fatty Liver Disease and Response to Treatment in Children  
  Jingmei Lin, Naga P Chalasani, Nature
• Liver Stiffness Measurements in Patients with Non‐Cirrhotic Portal Hypertension – the Devil Is in the Details  
  Niharika Samala, Raj Vuppalanchi, Naga Chalasani, Hepatology
• Common Variation near IRF6 Is Associated with IFN-Β-induced Liver Injury in Multiple Sclerosis  
  Joshua C Denny, Zongqi Xia, Naga Chalasani, Nature

Books/Book Chapters

• Drug Induced Liver Disease. 
  Vuppalanchi R, Chalasani NEditors: Kaplowitz N, DeLeve L.Marcel Dekker PublicationsEdition 3rd,2012
• Drug Induced Liver Injury: Epidemiology in the Western Countries. 
  Bell LN, Chalasani N2009
• Hepatology: A Textbook of Liver Disease. 
  Chapter: The Liver in Systemic Disease. 
  Chalasani N, Cummings OWEditors: Zakim D, Boyer TD.WB Saunders, Philadelphia, PAEdition 4th,2002

Abstracts/Posters

• Automatic quantification of liver histology in NAFLD. A promising tool to facilitate better histological characterization.
  Vanderbeck S, Bockhorst J, Komorowski R, Kleiner DE, Chalasani NP, Gawrieh S, Gastroenterology, DDW, 1/1/2014
• Little evidence for serious outcome in patients with chronic liver disease receiving potentially hepatotoxic drugs.
  Bjornsson E, Einarsdottir R, Jacobsen E, Chalasani NP, Gastroenterology, DDW, 1/1/2014
• Idiosyncratic drug induced liver injury in the United States: a report of 1257 prospectively enrolled patients.
  Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, et al, American College of Gastroenterology 2014 Annual Meeting, 1/1/2014

Lectures

• Initial Work-Up and Evaluation of a Patient With NAFLD 
  AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/8/2018
• Advances in Non-Alcoholic Fatty Liver Disease (NAFLD) 
  AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/8/2018
• Vitamin D deficiency in Chronic Liver Disease. 
  1/1/2012

Other

• NAFLD and it management. 
  Chalasani N (Series Ed), Clinical Liver Disease, an electronic publication of the AASLD
  1/1/2012